We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock
CERE

Delisted

CERE was delisted on the 31st of July, 2024.

Back to rankings

2 hedge funds and large institutions have $20.7K invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 228 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

99% less funds holding

Funds holding: 231 → 2 (-229)

100% less funds holding in top 10

Funds holding in top 10: 16 → 0 (-16)

100% less capital invested

Capital invested by funds: $6.42B → $20.7K (-$6.42B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 228

Holders
2
Holders Change
-229
Holders Change %
-99.13%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-16
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
228
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BTI
Blue Trust Inc
Georgia
+$297

Top Sellers

Rank Fund Capital Flow
1
BCI
Bain Capital Investors
Massachusetts
-$2.69B
2
PA
Perceptive Advisors
New York
-$441M
3
ACA
Avoro Capital Advisors
New York
-$308M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$293M
5
BlackRock
BlackRock
New York
-$146M
Name Holding Trade Value Shares
Change 		Change in
Stake
LC
201
Lindbrook Capital
California
– -$22.3K -546 Closed
US Bancorp
202
US Bancorp
Minnesota
– -$21.1K -517 Closed
HPC
203
HM Payson & Co
Maine
– -$20.4K -500 Closed
RTC
204
Riverview Trust Company
Washington
– -$15.7K -385 Closed
Comerica Bank
205
Comerica Bank
Texas
– -$15.4K -378 Closed
C
206
Covestor
United Kingdom
– -$12K -287 Closed
BHWM
207
Beaird Harris Wealth Management
Texas
– -$10.8K -265 Closed
Carson Wealth (CWM LLC)
208
Carson Wealth (CWM LLC)
Nebraska
– -$9K -225 Closed
Mitsubishi UFJ Asset Management
209
Mitsubishi UFJ Asset Management
Japan
– -$8.63K -211 Closed
S
210
SignatureFD
Georgia
– -$8.59K -210 Closed
SA
211
Scarborough Advisors
Maryland
– -$8.18K -200 Closed
Osaic Holdings
212
Osaic Holdings
Arizona
– -$7.16K -175 Closed
ETC
213
Exchange Traded Concepts
Oklahoma
– -$6.38K -156 Closed
SAM
214
Smartleaf Asset Management
Massachusetts
– -$5.87K -145 Closed
CI Investments Inc
215
CI Investments Inc
Ontario, Canada
– -$6K -139 Closed
QCG
216
Quadrant Capital Group
Ohio
– -$4.91K -120 Closed
AF
217
Allworth Financial
California
– -$4.76K -111 Closed
AIM
218
Anchor Investment Management
South Carolina
– -$4.09K -100 Closed
IUHSA
219
Itau Unibanco Holding S.A.
Brazil
– -$4.09K -100 Closed
EWA
220
EverSource Wealth Advisors
Alabama
– -$3.55K -79 Closed
TPCW
221
TD Private Client Wealth
New York
– -$3.19K -78 Closed
FFA
222
Farther Finance Advisors
California
– -$1.78K -43 Closed
RIL
223
Rothschild Investment LLC
Illinois
– -$1.02K -25 Closed
CA
224
Continuum Advisory
Idaho
– -$695 -17 Closed
PNC Financial Services Group
225
PNC Financial Services Group
Pennsylvania
– -$654 -16 Closed
6 7 8
9
10

CERE Hedge Fund Activity: Q3 2024 in Review

2 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q3 2024, worth a combined $20.7K — down 100% from $6.42B a quarter earlier.

Sellers outnumbered buyers: 228 funds closed out of CERE and 0 opened new positions — a net loss of 228 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Blue Trust Inc, adding an estimated $297. The largest seller was Bain Capital Investors, exiting entirely with an estimated $2.69B sold.

  • 2 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q3 2024, down from 231 in Q2 2024.
  • Funds reported $20.7K of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q3 2024 and 228 closed out, a net change of -228 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock buyer in Q3 2024 was Blue Trust Inc, an estimated $297 added.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q3 2024 was Bain Capital Investors, an estimated $2.69B sold.

Based on aggregated 13F filings for Q3 2024.